<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/342659</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;342659v1</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;342659</article-id><article-id pub-id-type="other" hwp:sub-type="slug">342659</article-id><article-id pub-id-type="other" hwp:sub-type="tag">342659</article-id><article-version>1.1</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Biochemistry" hwp:journal="biorxiv"><subject>Biochemistry</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">14-3-3 proteins activate <italic toggle="yes">Pseudomonas</italic> exotoxins-S and –T by chaperoning a hydrophobic surface</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>*</label><bold><italic toggle="yes">Corresponding author</italic></bold> – Herwig Schüler, email <email hwp:id="email-1">herwig.schuler@ki.se</email></corresp><fn fn-type="present-address" id="n1" hwp:id="fn-1"><p hwp:id="p-1"><bold><italic toggle="yes">Current addresses</italic></bold> – EVW: University of California, San Francisco Medical School, Department of Biochemistry and Biophysics.</p></fn></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Karlberg Tobias"><surname>Karlberg</surname><given-names>Tobias</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Hornyak Peter"><surname>Hornyak</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Filipa Pinto Ana"><surname>Filipa Pinto</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Milanova Stefina"><surname>Milanova</surname><given-names>Stefina</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Ebrahimi Mahsa"><surname>Ebrahimi</surname><given-names>Mahsa</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-4" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Lindberg Mikael"><surname>Lindberg</surname><given-names>Mikael</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-7"><name name-style="western" hwp:sortable="Püllen Nikolai"><surname>Püllen</surname><given-names>Nikolai</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-5" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-8"><name name-style="western" hwp:sortable="Nordström Axel"><surname>Nordström</surname><given-names>Axel</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-6" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-9"><name name-style="western" hwp:sortable="Löverli Elinor"><surname>Löverli</surname><given-names>Elinor</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-7" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-10"><name name-style="western" hwp:sortable="Caraballo Rémi"><surname>Caraballo</surname><given-names>Rémi</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-11"><name name-style="western" hwp:sortable="Wong Emily V."><surname>Wong</surname><given-names>Emily V.</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-1" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-12"><name name-style="western" hwp:sortable="Näreoja Katja"><surname>Näreoja</surname><given-names>Katja</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-8" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-13"><name name-style="western" hwp:sortable="Thorsell Ann-Gerd"><surname>Thorsell</surname><given-names>Ann-Gerd</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-9" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-14"><name name-style="western" hwp:sortable="Elofsson Mikael"><surname>Elofsson</surname><given-names>Mikael</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-2" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-15"><name name-style="western" hwp:sortable="De La Cruz Enrique M."><surname>De La Cruz</surname><given-names>Enrique M.</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-2" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-16"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7354-9270</contrib-id><name name-style="western" hwp:sortable="Björkegren Camilla"><surname>Björkegren</surname><given-names>Camilla</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-10" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-7354-9270"/></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-17"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4059-3501</contrib-id><name name-style="western" hwp:sortable="Schüler Herwig"><surname>Schüler</surname><given-names>Herwig</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-11" hwp:rel-id="aff-1">1</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0003-4059-3501"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3 xref-aff-1-4 xref-aff-1-5 xref-aff-1-6 xref-aff-1-7 xref-aff-1-8 xref-aff-1-9 xref-aff-1-10 xref-aff-1-11"><label>1</label><institution hwp:id="institution-1">Department of Biosciences and Nutrition, Karolinska Institutet</institution>, Huddinge, <country>Sweden</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2"><label>2</label><institution hwp:id="institution-2">Department of Cellular and Molecular Biology, Karolinska Institutet</institution>, Stockholm, <country>Sweden</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1"><label>3</label><institution hwp:id="institution-3">Protein Expertise Platform, Umeå University</institution>, Umeå, <country>Sweden</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1 xref-aff-4-2"><label>4</label><institution hwp:id="institution-4">Department of Chemistry, Umeå University</institution>, Umeå, <country>Sweden</country></aff><aff id="a5" hwp:id="aff-5" hwp:rev-id="xref-aff-5-1 xref-aff-5-2"><label>5</label><institution hwp:id="institution-5">Molecular Biophysics and Biochemistry, Yale University</institution>, New Haven, CT, <country>USA</country></aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2018"><year>2018</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2018-06-08T10:56:48-07:00">
    <day>8</day><month>6</month><year>2018</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2018-06-08T10:56:48-07:00">
    <day>8</day><month>6</month><year>2018</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2018-06-08T11:02:11-07:00">
    <day>8</day><month>6</month><year>2018</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2018-06-08T11:02:11-07:00">
    <day>8</day><month>6</month><year>2018</year>
  </pub-date><elocation-id>342659</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2018-06-08"><day>08</day><month>6</month><year>2018</year></date>
<date date-type="rev-recd" hwp:start="2018-06-08"><day>08</day><month>6</month><year>2018</year></date>
<date date-type="accepted" hwp:start="2018-06-08"><day>08</day><month>6</month><year>2018</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2018</copyright-year><license hwp:id="license-1"><p hwp:id="p-2">The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author’s permission.</p></license></permissions><self-uri xlink:href="342659.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/342659v1.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="342659.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/342659v1/342659v1.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/342659v1/342659v1.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-3"><italic toggle="yes">Pseudomonas</italic> are a common cause of hospital acquired infections that may be lethal. ADP-ribosyltransferase activities of <italic toggle="yes">Pseudomonas</italic> exotoxin-S and -T depend on 14-3-3 proteins inside the host cell. By binding in the 14-3-3 phosphopeptide binding groove, a hydrophobic C-terminal helix of ExoS and ExoT has been thought to be crucial for their activation. However, crystal structures of the 14-3-3β:ExoS and -ExoT complexes presented here reveal an extensive novel binding interface that is sufficient for complex formation and toxin activation. We show that C-terminally truncated ExoS ADP-ribosyltransferase domain lacking the hydrophobic binding motif is active when co-expressed with 14-3-3. Moreover, swapping the hydrophobic C-terminus with a fragment from <italic toggle="yes">Vibrio</italic> Vis toxin creates a 14-3-3 independent toxin that ADP-ribosylates known ExoS targets. Finally, we show that 14-3-3 stabilizes ExoS against thermal aggregation. Together, this indicates that 14-3-3 proteins activate exotoxin ADP-ribosyltransferase domains by chaperoning their hydrophobic surfaces independently of the hydrophobic C-terminal segment.</p><sec hwp:id="sec-1"><title hwp:id="title-2">Short summary</title><p hwp:id="p-4">Crystal structures of Pseudomonas exotoxins-S and –T identify a novel hydrophobic interface with 14-3-3 proteins, and we show that 14-3-3 activates these toxins independent of their phosphopeptide groove binding C-termini, by preventing their aggregation.</p></sec></abstract><counts><page-count count="31"/></counts></article-meta></front><body><p hwp:id="p-5"><italic toggle="yes">Pseudomonas aeruginosa</italic> is an opportunistic pathogen that is infamous for causing hospital acquired airway and wound infections. To initiate the infection process, the bacterium uses a type III secretion system to deliver a small set of exotoxins into the host cell.<sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>,<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref></sup> Two of these, exotoxins S and T (ExoS; ExoT) are homologous enzymes consisting of an N-terminal GTPase activating protein (GAP) domain (73% identity; 81% similarity) and a C-terminal ADP-ribosyltransferase (ART) domain (78% identity; 87% similarity).<sup><xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref>, <xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref></sup> Their GAP domains target Rho-family GTPases which leads to a remodeling of the host actin cytoskeleton. The activities of the ART domains are directed toward a more diverse set of proteins. ExoS targets Ras- and Rho-family GTPases,<sup><xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref>,<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref></sup> ezrin/radixin/moesin (ERM) proteins,<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7"><sup>7</sup></xref> and the intermediate filament protein, vimentin.<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8"><sup>8</sup></xref> ADP-ribosylation disturbs these targets presumably by placing the bulky ADP-ribose moiety in a protein-protein interaction site, and has multiple consequences including and disruption of actin polymers and their anchorage with focal adhesions leading to cell rounding. The cytotoxic effects of ExoS activity are likely due to disruption of Ras effector pathways.<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9"><sup>9</sup></xref> ExoT targets the adaptor molecules, CT10 Regulator of Kinase (CRK) and CRK-like (CRKL) and its activity leads to severe changes in cell morphology, presumably by rearrangement of the actin cytoskeleton.<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10"><sup>10</sup></xref> Most eukaryotic cells types utilize intrinsic ADP-ribosylation to regulate various vital processes; but exotoxin targets are not among the targets identified for human ADP-ribosyltransferases; and human ADP-ribosyl glycohydrolases appear to be unable to remove exotoxin mediated ADP-ribosylation.<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11"><sup>11</sup></xref> Inhibitors of ExoS ADP-ribosyltransferase activity may be viable for therapeutic intervention, as the ExoS ART domain with an intact catalytic activity is needed for bacterial dissemination in the <italic toggle="yes">Pseudomonas</italic> infected lung.<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12"><sup>12</sup></xref></p><p hwp:id="p-6">The ADP-ribosyltransferase activity of ExoS and ExoT and their cellular toxicity are dependent upon association of the ART domains with 14-3-3 proteins.<sup><xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref>,<xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref></sup> These are ubiquitous, abundant regulators of diverse signaling pathways, and act through hundreds of cellular targets. Seven human genes encode 14-3-3 isoforms, and post-translational modification and both homo- and heterodimerization contribute to the complexity of 14-3-3 functions.<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15"><sup>15</sup></xref><sup>-</sup><xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17"><sup>17</sup></xref> 14-3-3 proteins have extended hydrophobic surface patches<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18"><sup>18</sup></xref> and have recently been recognized to have chaperone-like functions.<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-2" hwp:rel-id="ref-15"><sup>15</sup></xref> However, their <italic toggle="yes">bona fide</italic> regulatory functions are mediated by recognition of phosphoserine or phosphothreonine residues in their targets. A number of crystal complex structures illustrate how target protein derived phosphorylated peptides bind to an amphipathic groove inside the bowl-shaped 14-3-3 dimer.<xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-2" hwp:rel-id="ref-17"><sup>17</sup></xref> By contrast, the interaction of ExoS with 14-3-3 proteins is phosphorylation independent, although it is mediated by a C-terminal segment of ExoS binding in the same groove.<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19"><sup>19</sup></xref><sup>-</sup><xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21"><sup>21</sup></xref> Previous work has clarified the importance of the hydrophobic side chains in a short sequence motif, <sup>426</sup>LDLA<sup>429</sup> in ExoS, in the interaction with 14-3-3 proteins and in <italic toggle="yes">Pseudomonas</italic> virulence.<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22"><sup>22</sup></xref><sup>-</sup><xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24"><sup>24</sup></xref> This motif (hereafter designated LDLA-box) is conserved in ExoT as well as in the putative 14-3-3 activated bacterial orthologues, AexT <xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25"><sup>25</sup></xref> and VopT.<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26"><sup>26</sup></xref> The extended LDLA-box has also been used as template for synthetic ExoS inhibitory peptides.<sup><xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref>, <xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref></sup> But whether and how 14-3-3 binding to this short hydrophobic sequence is connected to the catalytic activity of the toxins is unknown.</p><p hwp:id="p-7">We determined crystal structures of human 14-3-3β in complex with the ART domain of both ExoS and ExoT. This identified an extensive novel binding interface. ExoS constructs terminating at S419, and thus lacking the LDLA-box, bound 14-3-3β with sub-micromolar affinity; they were inactive when the complex was reconstituted, but had <italic toggle="yes">bona fide</italic> ExoS activity when co-expressed with 14-3-3β. We concluded that the core of the ExoS ART domain is competent for catalysis. This was supported by swapping the ExoS C-terminal segment including the LDLA-box with the C-terminal fragment of the 14-3-3 independent toxin Vis from <italic toggle="yes">Vibrio splendidus</italic>. The resulting chimeric toxin has ADP-ribosyltransferase activity toward ExoS targets in the absence of 14-3-3. Recombinant ExoS was prone to aggregation, and 14-3-3 stabilized ExoS during thermal aggregation. Collectively, our results indicate that 14-3-3 proteins act as exotoxin chaperones rather than activators.</p><sec id="s1" hwp:id="sec-2"><title hwp:id="title-3">Results</title><sec id="s1a" hwp:id="sec-3"><title hwp:id="title-4">Crystal structures of the ExoS:14-3-3β and ExoT:14-3-3β complexes</title><p hwp:id="p-8">ADP-ribosyltransferase activity of ExoS and ExoT requires 14-3-3 binding, but the mechanism of activation was unknown, and no structural models were available for any 14-3-3 activated toxin. We addressed these problems by X-ray crystallography and biochemical analyses. To identify suitable combinations of exotoxin ART domains and 14-3-3 isoforms to study, we evaluated 14-3-3 concentration dependent exotoxin activities <italic toggle="yes">in vitro</italic>. Six of the seven human 14-3-3 isoforms stimulated ExoS enzymatic activity to similar extent; 14-3-3σ had markedly lower apparent affinity; and 14-3-3β was the isoform with the highest apparent affinity for the toxin (<bold>Supplementary Fig. 1</bold>). We co-expressed 14-3-3β with either ExoS<sup>E379A,E381A</sup> or ExoT<sup>wt</sup> ART domains in <italic toggle="yes">Escherichia coli</italic> (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Fig. 1a</xref></bold>; for details, see the <bold>Supplementary Methods</bold> section). Using immobilized metal ion chromatography we isolated hexahistidine-tagged ADP-ribosyltransferase domains of either toxin – ExoS<sup>233-453(E379A,E381A)</sup> and ExoT<sup>235-435(wt)</sup> – in complex with untagged 14-3-3β. For both exotoxins, ion exchange chromatography on heparin sepharose, as well as consecutive size exclusion chromatography coupled to right-angle light scattering (SEC-RALS), indicated the formation of protein complexes of various constitutions. A protein complex with an apparent molecular weight of roughly 83.5 kDa (indicative of a “heterotrimer”: an ExoS<sup>E379A,E381A</sup> monomer bound to a 14-3-3β dimer; expected molecular weight 83246 Da; <bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Fig. 1b</xref></bold>) readily crystallized under various conditions. We obtained crystals in space group C2 that diffracted to 3.24 Å and contained one heterotrimer in the asymmetric unit. We solved the structure using molecular replacement with 14-3-3β and Vis toxin (PDB entries 2c23<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-2" hwp:rel-id="ref-21"><sup>21</sup></xref> and 4xzj<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29"><sup>29</sup></xref>) as search models (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Fig. 1c</xref></bold> and <bold><xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref></bold>). A complex with an apparent molecular weight of roughly 95 kDa (“heterotetramer”; expected molecular weight 104206 Da; <bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-4" hwp:rel-id="F1">Fig. 1d</xref></bold>) yielded crystals of space group P2<sub>1</sub>2<sub>1</sub>2 that diffracted to 3.24 Å (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-5" hwp:rel-id="F1">Fig. 1e</xref></bold>). Subsequent work (see <bold>Supplementary Methods</bold> for details) resulted in crystal structures of the 14-3-3β:ExoS <italic toggle="yes">apo</italic> heterotrimer at 2.34 Å, the heterotrimer with the non-hydrolyzable NAD<sup>+</sup> analog, carba-NAD in the active site at 2.50 Å (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-6" hwp:rel-id="F1">Fig. 1f,g</xref></bold>), and the heterotrimer with inhibitor STO1101<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30"><sup>30</sup></xref> at 3.24 Å resolution (<bold>Supplementary Fig. 2</bold>). The 14-3-3β:ExoT complexes showed a similar distribution of various molecular weight species (<bold>Supplementary Figs. 3,4</bold>). We determined the structure of the 14-3-3β:ExoT heterotetramer in complex with STO1101, however the model could not be refined beyond <sup>~</sup>3.80 Å resolution. The 14-3-3β complexes of ExoS and ExoT looked very similar overall (<bold>Supplementary Fig. 5</bold>), and the STO1101-bound ART domains alone (C chains) aligned with a root mean square deviation (RMSD) of 0.97 Å.<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31"><sup>31</sup></xref></p><fig id="fig1" position="float" orientation="portrait" fig-type="figure" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3 xref-fig-1-4 xref-fig-1-5 xref-fig-1-6 xref-fig-1-7 xref-fig-1-8"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;342659v1/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1</label><caption hwp:id="caption-1"><p hwp:id="p-9">Crystal structures of 14-3-3β:ExoS and 14-3-3β:ExoT complexes. (<bold>a</bold>) Schematic representation of co-expression constructs used for structure determination. Triangles represent the E379A,E381A double mutation. (<bold>b,d</bold>) SEC-RALS profiles of the heterotrimeric (c) and heterotetrameric (d) 14-3-3β:ExoS complexes (main peaks). Estimated molecular weights are indicated. (<bold>c,e</bold>) Structures of the 14-3-3β:ExoS heterotrimer (c) and heterotetramer (e). The 14-3-3β dimer is shown in gray. Numbers in italics indicate the ExoS residues that were resolved in the electron density. (<bold>f</bold>) Detail of the electron density around carba-NAD in the active site of ExoS (2F<sub>obs</sub> – F<sub>calc</sub> electron density map contoured at 1σ (0.1073 eÅ<sup>-3</sup>)). (<bold>g</bold>) Comparison of the ExoS <italic toggle="yes">apo</italic> and carba-NAD structures. The loop containing F354 is in two different conformations, where the open conformation from the <italic toggle="yes">apo</italic> structure is marked with an asterisk. Secondary structural elements are numbered. (<bold>h</bold>) Structure of the 14-3-3β:ExoT heterotetramer. (<bold>c</bold>,<bold>e</bold>,<bold>g</bold>,<bold>h</bold>) ExoS respectively ExoT are shown colored in a gradient from the N-terminus (blue) to the C-terminus (red) of the construct.</p></caption><graphic xlink:href="342659_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig></sec><sec id="s1b" hwp:id="sec-4"><title hwp:id="title-5">A novel interface between 14-3-3 and the <italic toggle="yes">Pseudomonas</italic> ART exotoxins</title><p hwp:id="p-10">Our crystal structures revealed an extensive novel interface between 14-3-3 and the ExoS and ExoT ART domains. This site involves the C-terminal α-helices-8 and -9 of 14-3-3β, and can be sub-divided into two parts: (i) The two proteins bury a common hydrophobic core made up of side chains originating from the 14-3-3β C-terminal helices and the central β-sheet of ExoS/T (primarily strands β4, β7 and β8; <bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Fig. 2a-c</xref></bold>). This sub-site constitutes roughly half of the total contact area between the two proteins (ExoS: 762 Å<sup>2</sup> out of 1580 Å<sup>2</sup>; ExoT: 766 Å<sup>2</sup> out of 1582 Å<sup>2</sup>).<xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32"><sup>32</sup></xref> (ii) The short segment that connects the LDLA-box containing exotoxin helix α7 with the core of the ART domain forms an extensive network of hydrogen bonds with the turn between 14-3-3β helices α8 and α9 (not shown). The entire interface between 14-3-3β and the ART domain is similar in ExoS and ExoT (<bold>Supplementary Fig. 5</bold>) and, based on protein sequence comparison, appears to be well conserved in other 14-3-3 dependent toxins (<bold>Supplementary Fig. 6</bold>).</p><fig id="fig2" position="float" orientation="portrait" fig-type="figure" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;342659v1/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2</label><caption hwp:id="caption-2"><p hwp:id="p-11">A novel interface between 14-3-3 and exotoxins S and -T. (<bold>a</bold>) Surface representation of the ExoS:14-3-3β complex. ExoS is shown in gold and one monomer of the 14-3-3β homodimer is shown in gray. The position of LDLA-box 1 in the amphipathic groove is indicated. (<bold>b</bold>) The partners in the complex rotated 90° away from each other to display the binding interface, colored to show surface charge distribution (blue, positive charges; red, negative charges; white, non-polar). Two key interactions are indicated to facilitate orientation. (<bold>c</bold>) Detail of the ExoS:14-3-3β interaction around ExoS β7-β8. The inset on top indicates the orientation of the main panel: The complex (as in <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-7" hwp:rel-id="F1">Fig. 1c</xref>) was rotated to the left and then down toward the viewer. Main panel: Sidechains of each protein that participate in interactions are shown (gold, ExoS; grey, 14-3-3β) and hydrogen bonds are indicated as dots. The binding site for PPI inhibitor NV1<sup>33</sup> is indicated by the NV1 structure (carbons in cyan). (<bold>d</bold>) Concentration dependent inhibition of ExoS K-Ras modification, and ExoT Crk modification, by the NV1 analog, STO1704. The chemical structure of STO1704 is shown.</p></caption><graphic xlink:href="342659_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-12">This novel interface between the exotoxins and 14-3-3 proteins might be a useful target for development of ExoS and ExoT inhibitors. Fortuitously, one of only few potential protein protein interaction (PPI) inhibitors known to bind 14-3-3 outside of the amphipathic groove, the compound NV-1, was shown to bind at the rim of the new ExoS/T binding site (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Fig. 2c</xref></bold>).<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33"><sup>33</sup></xref> We found that STO1704, a compound related to NV-1, inhibited K-Ras modification by ExoS<sup>233-453</sup> and CRK modification by ExoT<sup>235-457</sup> in a dose dependent manner (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Fig. 2d</xref></bold> and <bold>Supplementary Fig. 7</bold>). The potency is low (IC<sub>50</sub> 638 and 726 µM, respectively); nevertheless this provides proof-of-principle in support of PPI inhibitors as ExoS/T inhibitors.</p><p hwp:id="p-13">Our crystal structures of the 14-3-3β:ExoS and the 14-3-3β:ExoT ART domain complexes all revealed the bowl-shaped 14-3-3 dimer that aligned well with many previous structures of 14-3-3 isoforms (root mean square deviations of less than 1 Å over approximately 230 Cα-pairs). Neither the 14-3-3β dimer nor the toxin-bound 14-3-3β protomer show any significant conformational differences compared to the previous ExoS peptide bound structures.<sup><xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-3" hwp:rel-id="ref-21">21</xref>,<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref></sup> Thus our structures show that the LDLA-box in the context of the ART domain binds to 14-3-3 as the LDLA-box containing peptides, and in binding, does not distort the 14-3-3 structure: The ART domain and its C-terminal extension appear to wrap onto the solid scaffold of the 14-3-3 dimer.</p></sec><sec id="s1c" hwp:id="sec-5"><title hwp:id="title-6">A second LDLA-box binds the second 14-3-3 protomer in the heterotrimeric complex</title><p hwp:id="p-14">In all our protein complex structures, the phosphoprotein binding site of the exotoxin bound 14-3-3β protomer was occupied by a peptide containing the LDLA-box in a short α-helical segment (ExoS residues <sup>420</sup>QGLLDALDLAS<sup>430</sup>; <bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Fig. 3a</xref></bold>) in which the D427 side chain hydrogen bonded with the 14-3-3β Y127 and Y130 side chains, and the hydrophobic side chains formed hydrophobic interactions within the amphipathic groove of 14-3-3β (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Fig. 3b</xref></bold>). Both positioning and interaction pattern were virtually identical in previous crystal structures of ExoS derived peptides in complex with 14-3-3 protein s.<sup><xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-4" hwp:rel-id="ref-21">21</xref>,<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-2" hwp:rel-id="ref-23">23</xref></sup></p><fig id="fig3" position="float" orientation="portrait" fig-type="figure" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3 xref-fig-3-4 xref-fig-3-5 xref-fig-3-6 xref-fig-3-7 xref-fig-3-8 xref-fig-3-9"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;342659v1/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Figure 3</label><caption hwp:id="caption-3"><p hwp:id="p-15">A second LDLA-box is capable of binding the second 14-3-3 protomer. (<bold>a</bold>) Sequence alignment of 14-3-3 dependent toxins ExoS, ExoT, AexT, and VopT and, for comparison, the 14-3-3 independent Vis toxin. Presence of LDLA-box 1 (green arrowheads) unites all 14-3-3 dependent toxins; several also feature a second LDLA-box (orange arrowheads) at their very C-terminus. (<bold>b</bold>) ExoS LDLA-box 1 binding to the amphipathic groove of 14-3-3β and comparison to phosphopeptide binding at the same site (PDB entry 4o46). (<bold>c</bold>) ExoS LDLA-box 1 and -2 binding to the two 14-3-3β protomers. (<bold>d</bold>) Anisotropy of GFP-tagged ExoS constructs indicated tight binding of the ExoS ART domain (residues 233-453) to 14-3-3β. Truncation of LDLA-box 2 (residues 233-435) led to a slight reduction in apparent affinity. Truncation of both LDLA-boxes resulted in a protein (residues 233-419) that bound 14-3-3β with sub-micromolar affinity using only the novel binding site (<bold>Fig. 2</bold>). (<bold>e</bold>) Yeast toxicity assay of ExoS. Five-fold serial dilutions of yeast cells spotted on agar containing either glucose (target gene expression repressed) or galactose/raffinose (expression induced). Expression of the ExoS ADP-ribosyltransferase domain is highly toxic, unless the C-terminal segment ExoS<sup>420-453</sup>, containing both LDLA-boxes, is absent.</p></caption><graphic xlink:href="342659_fig3" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><p hwp:id="p-16">ExoS, ExoT and AexT of the 14-3-3 dependent ADP-ribosylating toxins contain a second LDLA motif (ExoS residues 450-453; designated LDLA-box 2) in their very C-termini (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Fig. 3a</xref></bold> and <bold>Supplementary Fig. 6</bold>). In one of our crystal structures of the 14-3-3β:ExoS heterotrimer, the residues connecting LDLA-box 1 and -2, E433 - D442, could not be modelled; but we found unambiguous electron density placing LDLA-box 2 in the phosphoprotein binding site of the second 14-3-3β monomer (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-8" hwp:rel-id="F1">Fig. 1c</xref></bold> and <bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-4" hwp:rel-id="F3">3c</xref></bold>). LDLA-box 2 bound in a configuration that was highly similar to the configuration of LDLA-box 1 in all four structures. This finding prompted us to examine the contribution of LDLA-box 2 to 14-3-3 binding. We used fluorescence anisotropy to estimate the affinities of 14-3-3β to N-terminal GFP fusions of ExoS<sup>233-435</sup> (containing only LDLA-box 1) and ExoS<sup>233-453</sup> (containing both LDLA-box 1 and -2, and the native C-terminus). The results indicate comparable affinities in the nanomolar range (~40 nM for GFP-ExoS<sup>233-453</sup>; ~70 nM for GFP-ExoS<sup>233-435</sup>; <bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-5" hwp:rel-id="F3">Fig. 3d</xref></bold> and <bold>Supplementary Fig. 8</bold>). These results were substantiated by <italic toggle="yes">in vivo</italic> toxicity assays using <italic toggle="yes">S.cerevisiae</italic>. The yeast has two orthologs of 14-3-3 proteins, Bmh1 and Bmh2, and the side chains contributing to the ExoS interactions in our crystal structures are largely conserved in both. Galactose-induced expression of either ExoS<sup>233-435</sup> or ExoS<sup>233-453</sup> conferred toxicity such that no colonies were formed on galactose containing agar plates (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-6" hwp:rel-id="F3">Fig. 3e</xref></bold>). Conversely, expression of ExoS<sup>233-419</sup> (lacking both LDLA-boxes) had no effect on colony formation compared to presence of the empty vector. We concluded that LDLA-box 2 binding to the second 14-3-3 protomer was an intriguing observation with possible implications for ExoS regulation. It is conceivable that LDLA-box 2 might participate in the formation of higher molecular weight 14-3-3:exotoxin complexes (<bold>Supplementary Fig. 3</bold>), or fold onto the ART domain. If such an event was coupled to catalytic activity, it could provide a layer of regulation; possibly, multimerization acts as a sensor for the presence of high amounts of exotoxin, i.e. conditions under which heterotetramer formation would liberate LDLA-box 2 from its binding site.</p></sec><sec id="s1d" hwp:id="sec-6"><title hwp:id="title-7">Mechanism of toxin activation</title><p hwp:id="p-17">The importance of LDLA-box 1 binding to the amphipathic groove of 14-3-3 is undisputed, <xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-2" hwp:rel-id="ref-22"><sup>22</sup></xref><sup>-</sup><xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-2" hwp:rel-id="ref-24"><sup>24</sup></xref> but its role has been unknown. Given the general sequence homology between these exotoxins and ADP-ribosylating toxins of known structure, we initially expected that 14-3-3 binding might unlock an active exotoxin conformation by sequestering the LDLA-box containing C-terminus. However, we could not reconcile the importance of LDLA-box 1 with our crystal structures. Site directed mutagenesis did not support a role for a structural link between 14-3-3 and the NAD<sup>+</sup> binding site in regulation of catalytic activity (<bold>Supplementary Fig. 9</bold> and <bold>Supplementary Table 2</bold>). Therefore, we asked whether the putative activating role of 14-3-3 could be substituted by the short carboxy-terminal sequence of a 14-3-3 independent but otherwise homologous toxin. Based on available crystal structures, we designed a chimeric toxin that comprised ExoS residues 233-409, followed by the C-terminus (residues 218-249)<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34"><sup>34</sup></xref> of Vis toxin (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Fig. 4a</xref></bold>). This construct, designated SxVis, displayed NAD<sup>+</sup> glycohydrolase activity and ADP-ribosylated K-Ras in the absence of 14-3-3 (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Fig. 4b</xref></bold>). Neither of these activities could be further stimulated by 14-3-3. ExoS alone had no activity without 14-3-3 present (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Fig. 4c</xref></bold>). Although SxVis catalytic efficiency (k<sub>cat</sub>/<italic toggle="yes">K</italic><sub>M</sub>) of K-Ras modification was &gt;40-fold lower than that of 14-3-3 activated ExoS, SxVis had a <italic toggle="yes">K</italic><sub>M</sub><sup>NAD</sup> in the same range as ExoS (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-4" hwp:rel-id="F4">Fig. 4c</xref></bold> and <bold><xref ref-type="table" rid="tbl2" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2">Table 2</xref></bold>) indicating a fully functional active site. These kinetics also indicate that LDLA-box 1 is involved in either target protein recognition or catalysis, but not NAD<sup>+</sup> binding.</p><fig id="fig4" position="float" orientation="portrait" fig-type="figure" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3 xref-fig-4-4 xref-fig-4-5 xref-fig-4-6 xref-fig-4-7 xref-fig-4-8 xref-fig-4-9 xref-fig-4-10"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;342659v1/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Figure 4</label><caption hwp:id="caption-4"><p hwp:id="p-18">The LDLA-boxes are dispensable for ExoS activity. (<bold>a</bold>) Schematic representation of the chimeric protein, SxVis, generated by C-terminal swapping. In the ExoS ART domain (gold), the C-terminal fragment (green) was replaced by that of Vis toxin (blue; PDB entry 4xzj). The position of the phosphopeptide groove binding LDLA-box 1 is indicated. (<bold>b</bold>) K-Ras modification (black) and NAD<sup>+</sup> glycohydrolase (GH) activity (blue) of SxVis alone (solid lines) and in presence of 2.5 molar excess of 14-3-3 (dotted lines). Rates (in μM εNAD<sup>+</sup> hydrolyzed/min) are indicated. (<bold>c</bold>) SxVis glycohydrolase activity (no 14-3-3) as a function of εNAD<sup>+</sup> concentration. The ExoS ART domain construct ExoS<sup>233-453</sup> is inactive under these conditions. (<bold>d</bold>) Schematic representation of ExoS ART domain construct ExoS<sup>233-419</sup> lacking the C-terminal LDLA-box containing fragment (green). (<bold>e</bold>) Ten-fold serial dilutions of <italic toggle="yes">E.coli</italic> cells transformed with ExoS expression vectors, spotted on agar containing either antibiotics (expression vector selection) or antibiotics and isopropyl β-D-1-thiogalactopyranoside (IPTG; expression induced). ExoS<sup>233-419</sup> elicits toxicity in <italic toggle="yes">E.coli</italic> when co-expressed with 14-3-3β. (<bold>f</bold>) K-Ras modification by ExoS<sup>233-419</sup> co-expressed with 14-3-3β, using εNAD<sup>+</sup> as co-substrate. Rates (in μM εNAD<sup>+</sup> hydrolyzed/min) are indicated. Reconstituted ExoS<sup>233-419</sup>: 14-3-3β complex is inactive under identical conditions. (<bold>g</bold>) K-Ras modification by ExoS<sup>233-419</sup> co-expressed with 14-3-3β, using fluo-NAD<sup>+</sup> as co-substrate. ExoS<sup>233-419</sup> carrying the E379A,E381A mutation, co-expressed with 14-3-3β, is shown as control. Controls and an uncropped version of the gel are provided as <bold>Supplementary Figs. 10-13</bold>. (<bold>h</bold>) Co-expressed ExoS<sup>233-419</sup>: 14-3-3β complex activity as a function of K-Ras concentration. Kinetic properties are reported in <bold><xref ref-type="table" rid="tbl2" hwp:id="xref-table-wrap-2-2" hwp:rel-id="T2">Table 2</xref></bold>. (<bold>i</bold>) ExoS<sup>233-453</sup> in presence of 14-3-3β at varying molar ratio (0 − 2, as indicated) was heated at 0.4 K/min while light scattering was measured using a DLS detector. Inset: Half-temperatures of aggregation as a function of [14-3-3β] added. 14-3-3β stabilizes ExoS<sup>233-453</sup> against heat induced aggregation. (<bold>j</bold>) Model of ExoS activation. ExoS has the intrinsic requirements for ADP-ribosyltransferase activity, but is aggregation prone. Aggregation is reversible as long as the LDLA-boxes are accessible to initiate 14-3-3 mediated de-aggregation. Aggregation is prevented by co-expression with 14-3-3, irrespective of the presence of the LDLA-boxes.</p></caption><graphic xlink:href="342659_fig4" position="float" orientation="portrait" hwp:id="graphic-4"/></fig><p hwp:id="p-19">These findings, in combination with the observation (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-7" hwp:rel-id="F3">Fig. 3d</xref></bold>) that 14-3-3β had considerable affinity for ExoS<sup>233-419</sup> (lacking both LDLA-boxes; <bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-5" hwp:rel-id="F4">Fig. 4d</xref></bold>) prompted us to co-express ExoS<sup>233-419</sup> with 14-3-3β. We found that expression of this protein complex elicited toxicity in <italic toggle="yes">E.coli</italic>, and this toxicity was dependent on the presence of the catalytic glutamates (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-6" hwp:rel-id="F4">Fig. 4e</xref></bold>). This was in line with our initial observation that expression of complex containing the full wild type ART domain was toxic. However, we could identify conditions under which protein complex could be produced (<bold>Methods</bold>). We found that the native complex of ExoS<sup>233-419</sup> and 14-3-3β, when purified from cells co-expressing the proteins, ADP-ribosylated K-Ras and had NAD<sup>+</sup> glycohydrolases activity, whereas the reconstituted complex was inactive (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-7" hwp:rel-id="F4">Fig. 4f,g,h</xref></bold> and <bold>Supplementary Fig. 10-13</bold>). These findings suggested that LDLA-box 1 is dispensable for ExoS activity, but is needed for other reasons. Since bacterial expression of all exotoxin constructs induced the formation of inclusion bodies, we studied the effect of 14-3-3 on ExoS stability. Using dynamic light scattering, we observed that ExoS<sup>233-453</sup> formed aggregates, with an onset temperature of 46.7 °C (<bold>Supplementary Table 3</bold>). Sub-stoichiometric amounts of 14-3-3β were able to elevate the transition temperature of ExoS aggregation (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-8" hwp:rel-id="F4">Fig. 4i</xref></bold>). The stabilizing effect of 14-3-3β was abrogated by the PPI inhibitor STO1704, whereas carbonic anhydrase, an unrelated protein, had no effect on ExoS aggregation (<bold>Supplementary Table 3</bold> and <bold>Supplementary Fig. 14</bold>). Together, this leads us to conclude that 14-3-3 activation of ExoS does not involve a structural transition to enable substrate or target binding, but rather, is a consequence of chaperoning hydrophobic surfaces to prevent the ART domain from aggregating (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-9" hwp:rel-id="F4">Fig. 4j</xref></bold>).</p></sec></sec><sec id="s2" hwp:id="sec-7"><title hwp:id="title-8">Discussion</title><sec id="s2a" hwp:id="sec-8"><title hwp:id="title-9">Mechanism of exotoxin activation</title><p hwp:id="p-20">While it is well documented that LDLA-box 1 is crucial for exotoxin activity <italic toggle="yes">in vivo</italic>, we showed here that the ExoS ART domain is intrinsically active, and that LDLA-box 1 is dispensable for 14-3-3 mediated exotoxin activity <italic toggle="yes">in vitro</italic>. Our results also indicate that the novel 14-3-3 binding site in the exotoxins is an aggregation prone surface that needs chaperoning. Thus we might assume that <italic toggle="yes">in vivo</italic>, the exotoxin C-terminus recruits 14-3-3 proteins early during passage through the type 3 secretion system and thereby ensures fast binding of the hydrophobic surface to its chaperone. Some T3SS targets have been shown to traverse the needle complex “head on”, starting with the translocation signal containing Nterminus.<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35"><sup>35</sup></xref> 14-3-3 dependent exotoxins also contain a translocation signal in their Ntermini,<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-2" hwp:rel-id="ref-1"><sup>1</sup></xref> but it is unknown whether they enter host cells starting with their N- or their C-terminal end.</p><p hwp:id="p-21">Co-expression of ExoS<sup>253-419</sup> with 14-3-3β was found to be toxic to bacteria (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-10" hwp:rel-id="F4">Fig. 4e</xref></bold>), while overexpression of the same construct was not toxic to yeast (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-8" hwp:rel-id="F3">Fig. 3e</xref></bold>). Although the exotoxin interacting residues appear to be conserved in the yeast 14-3-3 orthologs, it is feasible that the short constructs binds these proteins with lower affinity than human 14-3-3 proteins. However, the two experimental systems are sufficiently different to exclude a straightforward conclusion regarding the lack of yeast toxicity of this ExoS construct.</p></sec><sec id="s2b" hwp:id="sec-9"><title hwp:id="title-10">Novel binding site</title><p hwp:id="p-22">The main contact site between 14-3-3β and the ART domains overlaps with the newly discovered binding interface between the yeast 14-3-3 ortholog, Bmh1, and trehalase.<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36"><sup>36</sup></xref> The modes of interaction are different however, as an α-helical segment (S722-G729) of trehalase resides in the hydrophobic groove formed by Bmh1 helices-8 and -9 roughly perpendicular to the orientation of the ExoS/T β-strands in our complexes. Structures of other complexes of 14-3-3 with client proteins have been determined as well,<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37"><sup>37</sup></xref><sup>-</sup><xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39"><sup>39</sup></xref> but the binding sites for these proteins show only minor overlap with the ExoS/T binding site (<bold>Supplementary Fig. 12</bold>). In a development of pharmacological interventions involving the novel exotoxin binding site, it will be important to address the question of whether other proteins interact at this site.</p></sec><sec id="s2c" hwp:id="sec-10"><title hwp:id="title-11">Substrate recognition site</title><p hwp:id="p-23">Barbieri and coworkers defined a “region A” (ExoT<sup>246-264</sup>) near the N-terminus of the domain as critical for substrate recognition by ExoT.<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40"><sup>40</sup></xref> Our crystal structures show that regions A of both ExoS and –T fold into two helices (α1 and α2), unlike the corresponding region with low homology in related toxins (<bold>Supplementary Fig. 16</bold>). We noted differential effects of our F327R mutant depending on whether a proteinaceous substrate or a free arginine analog was available (<bold>Supplementary Table 2</bold>). As α1 and α2 locate close to the NAD<sup>+</sup> containing active site loop, it is plausible that target protein binding at this site would influence the affinity of ExoS for NAD<sup>+</sup>.</p></sec><sec id="s2d" hwp:id="sec-11"><title hwp:id="title-12">Future perspectives</title><p hwp:id="p-24">Our crystal structures provide important information for a better understanding of 14-3-3 dependent toxins, and also for the development of enzyme inhibitors as potential anti-infectives. However, our discoveries of an exotoxin chaperone function of 14-3-3, of the novel interaction site between the proteins, and of the inhibitory effect of STO1704, encourage development of specific PPI inhibitors of 14-3-3 dependent exotoxin activation. This is especially important as compounds binding to an exotoxin specific site would circumvent the off-target effects expected of inhibitors that bind in the amphipathic groove of 14-3-3 protein s.<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41"><sup>41</sup></xref></p></sec></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-13">Acknowledgments</title><p hwp:id="p-25">We thank Pontus Aspenström, Åke Forsberg, Tomas Nyman, Charlotta Sundin and Yngve Östberg for contributing cDNA, and the Protein Science Facility at Karolinska Institutet/SciLifeLab for molecular cloning and providing access to equipment. We thank the beamline staff at the synchrotron radiation facilities BESSY (Berlin, Germany), ESRF (Grenoble, France) and Diamond (Didcot, UK) for excellent support. This work was supported by the Swedish Foundation for Strategic Research (SB12-0022; to MEl and HS), the Swedish Research Council (2012-2802; to MEl, 2015-4200; to CB and 2015-4603; to HS), the IngaBritt and Arne Lundbergs Research Foundation (403 and 2015-089; to HS), National Institutes of Health (R01 Grant GM097348; to EMDLC). EVW was supported by a National Science Foundation Graduate Research Fellowship (DGE-1122492) and KN by a Wenner-Gren Foundation fellowship.</p></ack><sec id="s3" hwp:id="sec-12"><title hwp:id="title-14">Author contributions</title><p hwp:id="p-26">Conceptualization: TK, PH, HS. Methodology: TK, PH, AFP, EVW, EMDLC, CB, HS. Investigation and validation: TK, PH, AFP, SM, MEb, NP, AN, EL, AGT, HS. Resources: ML, RC, MEl. Formal Analysis: TK, EVW, KN, EMDLC. Writing – Original Draft Preparation: HS. Writing – Review &amp; Editing: All authors. Visualization: TK, HS. Supervision: MEl, EMDLC, CB, HS. Project Administration: HS. Funding Acquisition: MEl, EMDLC, CB, HS.</p><table-wrap id="tbl1" position="float" orientation="portrait" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;342659v1/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-5"><p hwp:id="p-27">Data collection and refinement statistics</p></caption><graphic xlink:href="342659_tbl1" position="float" orientation="portrait" hwp:id="graphic-5"/></table-wrap><table-wrap id="tbl2" position="float" orientation="portrait" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1 xref-table-wrap-2-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;342659v1/TBL2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tbl2</object-id><label>Table 2.</label><caption hwp:id="caption-6"><p hwp:id="p-28">Kinetic constants for ExoS and ExoT ADP-ribosyltransferase domain activity.<sup>a</sup></p></caption><graphic xlink:href="342659_tbl2" position="float" orientation="portrait" hwp:id="graphic-6"/></table-wrap></sec><sec id="s4" hwp:id="sec-13"><title hwp:id="title-15">Methods</title><sec id="s4a" hwp:id="sec-14"><title hwp:id="title-16">Materials</title><p hwp:id="p-29">Fine chemicals and growth media were purchased from SigmaAldrich. 1,<italic toggle="yes">N</italic><sup>6</sup>-fluoresceinyl-NAD<sup>+</sup> (fluo-NAD<sup>+</sup>) was obtained from BioLog, and 1,<italic toggle="yes">N</italic><sup>6</sup>-etheno-AMP from Jena Bioscience. The non-hydrolyzable NAD analog carbanicotinamide adenine dinucleotide (carba-NAD; PubChem ID 112345-60-5) was synthesized as described before, <xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44"><sup>44</sup></xref> with minor modifications. <sup>1</sup>H- and <sup>13</sup>C-NMR spectra (<bold>Supplementary Fig. 17</bold>) were in agreement with the original report. ExoS/T inhibitor STO1101 (3-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)propanoic acid; PubChem ID 412962-43-7) was purchased from Enamine (cat. no. Z96229612).<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-2" hwp:rel-id="ref-30"><sup>30</sup></xref> PPI inhibitor STO1704 (N-(2-ethyl-6-methylphenyl)-2-[2-(1-hydroxyethyl)-1H-benzimidazol-1-yl]-N-(2-methoxy-1-methylethyl)acetamide) was purchased from ChemBridge (cat. no. 6944250).</p></sec><sec id="s4b" hwp:id="sec-15"><title hwp:id="title-17">Molecular cloning</title><p hwp:id="p-30">The cDNA fragments encoding ExoS residues 233-453 and ExoT residues 235-457, sub-cloned in pET28a (Novagen) to obtain an N-terminal hexahistidine fusion, were contributed by Yngve Östberg (Umeå University). Other exotoxin encoding cDNA fragments were PCR-amplified from extracts of <italic toggle="yes">P. aeuruginosa</italic> PAK cells, contributed by Charlotta Sundin and Åke Forsberg (Umeå University). ExoS<sup>419-453</sup> cDNA was sub-cloned in pNic-trx (provided by the Protein Science Facility at Karolinska Institutet/SciLifeLab), encoding an N-terminal thioredoxin followed by a hexahistidine tag; all other exotoxin encoding DNA constructs were sub-cloned in pNic28-Bsa4 (GenBank: <ext-link l:rel="related" l:ref-type="genbank" l:ref="EF198106.1" ext-link-type="gen" xlink:href="EF198106.1" hwp:id="ext-link-1">EF198106.1</ext-link>) to obtain N-terminal hexahistidine fusion constructs. Expression plasmids containing the 14-3-3 encoding cDNAs YWHAB (pTvHR21-SGC), YWHAG (pTvHR21-SGC), YWHAE (pLic-SGC1), YWHAH (pNic28-Bsa4), YWHAQ (pNic28-Bsa4), YWHAS (pGEX2TK) and YWHAZ (pGEX4T1) were contributed by the Structural Genomics Consortium and obtained from Addgene. The 14-3-3ζ encoding cDNA YWHAZ was also sub-cloned in pNic28-Bsa4 to obtain an N-terminal hexahistidine fusion construct. Expression plasmids for other ExoS fragents were based on vector pNICBsa4 or pET28a, and have been described.<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-3" hwp:rel-id="ref-30"><sup>30</sup></xref> Green fluorescent protein (GFP)-tagged ExoS expression vectors were constructed by sub-cloning ExoS<sup>233-419</sup>, ExoS<sup>233-435</sup>, ExoS<sup>233-453</sup>, and ExoS<sup>419-453</sup> in pET-GFP1a.<xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45"><sup>45</sup></xref> An ExoS:14-3-3β co-expression vector was constructed by sub-cloning a cDNA fragment encoding the E379A,E381A mutant of ExoS<sup>233-453</sup> and the cDNA encoding 14-3-3β<sup>1-239</sup> into pET-Duet1 (Novagen). An ExoT:14-3-3β co-expression vector was constructed by replacing the ExoS cDNA sequence with the wild type ExoT<sup>235-457</sup> cDNA in pET-Duet1. The coding regions for human Rnd1 and Rac3 were contributed by Pontus Aspenström (Karolinska Institutet) and sub-cloned in pNic28-Bsa4 to obtain N-terminal hexahistidine fusion constructs. Expression vector pET28-MHL-KRASb was contributed by the Structural Genomics Consortium and obtained from Addgene. Expression vector pNICH102<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46"><sup>46</sup></xref> encoding ExoT target protein CRK<sup>1-S115</sup> (the SH2 domain) with an N-terminal decahistidine tag was contributed by Tomas Nyman (Karolinska Institutet, Protein Science Facility). SxVis (ExoS<sup>233-409</sup> fused to Vis<sup>218-249</sup>) and the ExoS<sup>233-419</sup> solubilization mutant were obtained as synthetic clones and sub-cloned in pET151b (GeneArt/ThermoFischer Scientific).</p></sec><sec id="s4c" hwp:id="sec-16"><title hwp:id="title-18">Protein expression and purification</title><p hwp:id="p-31">Generally, proteins were expressed in <italic toggle="yes">Escherichia coli</italic> strains BL21(DE3) (Stratagene) or T7Express (New England Biolabs) in rich medium (Terrific Broth + 8 g/L glycerol), by induction of expression during logarithmic growth phase using 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG), followed by bacterial growth overnight at 18 °C. The ExoS<sup>233-419</sup> constructs (ART domains with C-termini deleted) were co-expressed with 14-3-3β in <italic toggle="yes">E.coli</italic> strain T7Express <italic toggle="yes">lysY</italic> (New England Biolabs) by induction with 1 mM IPTG for 3 hours at 37°C. The ExoS:14-3-3β and ExoT:14-3-3β complexes were purified by immobilized metal affinity chromatography (IMAC)- employing a hexahistidine tag on the exotoxins, followed by size exclusion chromatography (SEC), followed by ion exchange chromatography (IEX) on HiTrap Heparin columns (GE Healthcare). Purification of ExoS, ExoT and CRK was by IMAC followed by SEC. The GTPases were purified by IMAC followed by IEX (HiTrap Q-sepharose for K-Ras; HiTrap SP-sepharose for Rac3 and Rnd1). Precipitation of GTPases was minimized by addition of 0.2 mM GTP and 0.2 mM MgCl<sub>2</sub> to column fractions. 14-3-3 isoforms were expressed as either hexahistidine fusions and purified by IMAC, or glutathione S-transferase (GST) fusions and purified using glutathione sepharose 4B (GE Healthcare). 14-3-3 proteins were further purified by hydrophobic interaction chromatography (HIC) on Phenyl Sepharose-6 Fast Flow High Sub (GE Healthcare) using a linear gradient of 2.5 to 0 M NaCl in 50 mM sodium phosphate pH 7.0, 1 mM TCEP, followed by SEC. All proteins were concentrated by ultrafiltration on Vivaspin devices (Sartorius) and stored as aliquots at -80°C. Protein concentrations were determined using a Nanodrop device (ThermoFisher Scientific) and calculated based on theoretical extinction coefficients. GTPase concentrations (batches containing GTP) were determined using the Bradford assay (ThermoFisher Scientific, 23236) and the albumin standard provided by the manufacturer.</p></sec><sec id="s4d" hwp:id="sec-17"><title hwp:id="title-19">Protein complex analyses</title><p hwp:id="p-32">Protein complexes were subjected to size exclusion chromatography - right angle light scattering (SEC-RALS) using a 10/300 Superdex-200 HR column mounted on an ÄKTA Pure chromatography system (GE Healthcare) followed by light scattering analysis using a 8-µl flow cell in a Zetasizer µV instrument (Malvern Instruments). Light scattering analyses were calibrated using bovine serum albumin dissolved in the experimental buffer and analyzed using OmniSEC software (Malvern Instruments).</p></sec><sec id="s4e" hwp:id="sec-18"><title hwp:id="title-20">Protein crystallization and X-ray crystallographic analysis</title><p hwp:id="p-33">Initial work toward a crystal structure is detailed in the <bold>Supplementary Methods</bold> section. Initial crystals of an ExoS:14-3-3β complex of an estimated molecular weight of 83 kDa were obtained by vapor diffusion in sitting drops at 4°C. Drops contained 0.15 μl protein (27.6 mg/ml) and 0.15 μl precipitant solution (23% PEG3350, 0.1 M HEPES pH 7.2). Diffraction data were collected from needle crystals at BESSY beamline BL14.1 (wavelength 0.91841 Å) and processed using XDSAPP.<xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47"><sup>47</sup></xref> Data extended to 3.22Å resolution, and the space group was C2 (cell parameters a= 134.46 Å, b= 57.31 Å, c= 128.67 Å, β=112.02°). The asymmetric unit contained two 14-3-3β monomers and one ExoS molecule. The structure was solved by molecular replacement using PDB entries 2c23 (14-3-3β) and 4xzj (Vis toxin) as search model.<sup><xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-5" hwp:rel-id="ref-21">21</xref>,<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-2" hwp:rel-id="ref-29">29</xref></sup> The resulting structure (<bold>Supplementary Table 1</bold>) served as molecular replacement template for all following datasets.</p><p hwp:id="p-34">Diffraction data were indexed, integrated using XDS,<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48"><sup>48</sup></xref> scaled and truncated using SCALA<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49"><sup>49</sup></xref> or XSCALE and the CCP4 suite of programs. BESSY synchrotron diffraction data were processed using XDSAPP.<xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-2" hwp:rel-id="ref-47"><sup>47</sup></xref> The structures were solved by molecular replacement with PHASER.<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50"><sup>50</sup></xref> All structures were refined using phenix.refine<xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51"><sup>51</sup></xref> or Buster, <xref ref-type="bibr" rid="c52" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52"><sup>52</sup></xref> and model building was done with Coot.<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-1" hwp:rel-id="ref-53"><sup>53</sup></xref></p><p hwp:id="p-35">Analysis of the structure showed a crystal packing that allowed the 14-3-3β C-terminus to insert in the active site of ExoS in a neighbor unit cell (<bold>Supplementary Fig. 3g,h</bold>). We redesigned the co-expression vector, substituting the full length 14-3-3β cDNA with a cDNA coding for a construct truncated after N234. The resulting protein complex yielded crystals in space group C2 that diffracted to 2.34 Å (apo form) and that could be used to determine structures of ligand complexes after soaking (<bold><xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Table 1</xref></bold>).</p></sec><sec id="s4f" hwp:id="sec-19"><title hwp:id="title-21">Enzymatic analyses</title><p hwp:id="p-36">General ExoS assays contained 100 nM ExoS<sup>233-453</sup>, 500 nM 14.3.3β, and 25 µM εNAD<sup>+</sup> in 20 mM HEPES pH 7.5, 50 mM NaCl, 4 mM MgCl<sub>2</sub> and 0.5 mM TCEP. General ExoT assays contained 200 nM ExoT<sup>235-457,</sup> 800 nM 14.3.3β, and 100 µM εNAD<sup>+</sup>. Target proteins were added either at variable concentrations (to determine <italic toggle="yes">K</italic><sub>M</sub><sup>target</sup>) or at a concentration near <italic toggle="yes">K</italic><sub>M</sub><sup>target.</sup> For negative control reactions, 14-3-3 protein was omitted. Assays were carried out in black flat bottom half area 96-well plates (Greiner 675076) in final volumes of 50 µL. Enzymatic reactions, at ambient temperature (22°C), were started by addition of εNAD<sup>+</sup>, and fluorescence was followed over time in a CLARIOstar multimode platereader (BMG Labtech) using λ<sub>ex</sub> = 302/10 nm (filter) and λ<sub>em</sub> = 410/10 nm (monochromator). All kinetic parameters were determined based on fluorescence increase in the linear time range (typically 10-15 minutes). Fluorescence was related to concentrations of fluorescent product using serial dilution of 1,<italic toggle="yes">N</italic><sup>6</sup>-etheno-AMP (Jena Bioscience). Fluorescence data were analyzed and kinetic and binding parameters calculated using Prism (Graph Pad Software).</p><p hwp:id="p-37">Visualization of substrate protein modification was carried out in essence as above, but with fluo-NAD<sup>+</sup> as co-substrate. Enzymatic reactions were separated by SDS-PAGE on 14% Tris-Glycine gels (ThermoFisher XP0014) and imaged on a UV-transluminator before Coomassie staining.</p><p hwp:id="p-38">Enzyme inhibition assays (PPI inhibitors) contained either 50 nM ExoS, 50 nM 14-3-3β, 25 μM Rac3, and 40 µM εNAD<sup>+</sup>, or 80 nM ExoT, 80 nM 14-3-3β, 15 μM CRK SH2 domain, and 40 µM εNAD<sup>+</sup>. They also contained 3% DMSO and compounds at between 31.25 and 1000 μM. Inhibition was evaluated from ADP-ribosyltransferase rates at different compound concentrations, and EC<sub>50</sub> values were determined by four parameter curve fitting of the rate data (N=2; n=4).</p></sec><sec id="s4g" hwp:id="sec-20"><title hwp:id="title-22">Fluorescence anisotropy assay of ExoS–14-3-3 interaction</title><p hwp:id="p-39">GFP-ExoS protein constructs were pre-incubated with 14-3-3 proteins in 20 mM HEPES, 150 mM NaCl, 1 mM TCEP, pH 7.5, and parallel and perpendicular GFP-fluorescence intensities were determined in a CLARIOstar multimode plate reader (BMG Labtech) using λ<sub>ex</sub> = 482/16 nm, λ<sub>em</sub> = 530/40 nm, and a bandpass of 504/10 nm. Anisotropy was calculated according to the following equation:
<disp-formula id="ueqn1" hwp:id="disp-formula-1"><alternatives hwp:id="alternatives-1"><graphic xlink:href="342659_ueqn1.gif" position="float" orientation="portrait" hwp:id="graphic-7"/></alternatives></disp-formula></p><p hwp:id="p-40">Where r is anisotropy, <italic toggle="yes">I</italic><sub>||</sub> is the fluorescence intensity parallel to the excitation light, and <italic toggle="yes">I</italic><sub>⊥</sub> is the fluorescence intensity perpendicular to the excitation light. Apparent binding constants were calculated by fitting anisotropy to a quadratic binding equation using Microcal Origin:
<disp-formula id="ueqn2" hwp:id="disp-formula-2"><alternatives hwp:id="alternatives-2"><graphic xlink:href="342659_ueqn2.gif" position="float" orientation="portrait" hwp:id="graphic-8"/></alternatives></disp-formula></p><p hwp:id="p-41">where r is the anisotropy of the population of GFP-ExoS in solution, r<sub>0</sub> is the initial anisotropy (in the absence of 14-3-3, r<sub>∞</sub> is the anisotropy of GFP-ExoS at saturating [14-3-3], P<sub>T</sub> is the total [14-3-3], L<sub>T</sub> is the total GFP-ExoS, and <italic toggle="yes">K</italic><sub>d,app</sub> is the apparent binding affinity of GFP-ExoS for 14-3-3.</p></sec><sec id="s4h" hwp:id="sec-21"><title hwp:id="title-23">Thermal aggregation assay by dynamic light scattering (DLS)</title><p hwp:id="p-42">ExoS<sup>233-453</sup> (10 μM) and 14-3-3β (variable) were pre-incubated in 20 mM HEPES, 300 mM NaCl, 10% Glycerol, 1 mM TCEP, pH 7.5. Samples were cleared of aggregates in a table top centrifuge (17500 x g; 30 min, 4 °C). DLS analyses were performed on 50 μl of the supernatant in a quartz cuvette using a detector at 90 degrees from the incident laserbeam in a Zetasizer μV instrument (Malvern). Protein stability was assessed using a temperature gradient from 25 to 70°C. Z-average size was plotted against temperature and the aggregation onset temperature was determined by extrapolating the linear section of the transition, at its highest slope, backward to its intersection with the baseline at low temperatures.</p></sec><sec id="s4i" hwp:id="sec-22"><title hwp:id="title-24">Assay of protein toxicity in yeast</title><p hwp:id="p-43">ExoS<sup>233-419</sup>, ExoS<sup>233-435</sup>, ExoS<sup>233-453</sup> sequences were amplified by PCR and integrated downstream the galactose-inducible GAL1-10 promoter in the yeast integrative plasmid vector YIplac211. Correct integration was controlled by DNA sequencing. Plasmids were linearized using the StuI restriction enzyme (Roche), and integrated at the URA3 locus in the budding yeast <italic toggle="yes">Saccharomyces cerevisiae</italic> W303 using lithium acetate-mediated transformation.<xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54"><sup>54</sup></xref> The genotypes of the resulting strains are listed in <bold>Supplementary Table 4</bold>. To evaluate the viability of yeast strains expressing the different ExoS variants, a volume equivalent to OD<sub>600</sub> = 3 of mid-log phase cells grown in YEP media supplemented with 2% glucose were harvested using centrifugation. Resulting cell pellets were resuspended in 1 ml sterile water, and 3 µl of 5-fold serial dilutions were spotted on YEP plates supplemented with 2% glucose (expression “off”), or with 2% raffinose and 2% galactose (expression “on”). Images shown in <bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-9" hwp:rel-id="F3">Fig. 3e</xref></bold> were taken after 24 h incubation at 30°C.</p></sec><sec id="s4j" hwp:id="sec-23"><title hwp:id="title-25">Assay of protein toxicity in <italic toggle="yes">E.coli</italic></title><p hwp:id="p-44">Cells of strain T7Express <italic toggle="yes">lysY</italic> (New England Biolabs) were transformed with expression plasmids and grown on agar overnight. Liquid cultures (Lucia Broth) were prepared and allowed to grow at 37°C to saturation. New liquid cultures (Terrific Broth) were inoculated and allowed to grow at 37°C to OD<sub>600</sub> of 1.0 – 1.2. Cultures were diluted to OD<sub>600</sub> of 0.1 using either Terrific Broth or Terrific Broth supplemented with 1 mM IPTG. Serial dilutions were prepared of which 10 μl were spotted on either agar or agar supplemented with 1 mM IPTG. Plates were imaged after overnight incubation at 37°C.</p></sec></sec><ref-list hwp:id="ref-list-1"><title hwp:id="title-26">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1 xref-ref-1-2"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Yahr T.L."><surname>Yahr</surname>, <given-names>T.L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goranson J."><surname>Goranson</surname>, <given-names>J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Frank D.W."><surname>Frank</surname>, <given-names>D.W.</given-names></string-name> <article-title hwp:id="article-title-2">Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway</article-title>. <source hwp:id="source-1">Mol. Microbiol.</source> <volume>22</volume>, <fpage>991</fpage>–<lpage>1003</lpage> (<year>1996</year>).</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><label>2.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Frithz-Lindsten E."><surname>Frithz-Lindsten</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Du Y."><surname>Du</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rosqvist R."><surname>Rosqvist</surname>, <given-names>R.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Forsberg A."><surname>Forsberg</surname>, <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-3">Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments</article-title>. <source hwp:id="source-2">Mol. Microbiol.</source> <volume>25</volume>, <fpage>1125</fpage>–<lpage>1139</lpage> (<year>1997</year>).</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Simon N.C."><surname>Simon</surname>, <given-names>N.C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Aktories K."><surname>Aktories</surname>, <given-names>K.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Barbieri J.T."><surname>Barbieri</surname>, <given-names>J.T.</given-names></string-name> <article-title hwp:id="article-title-4">Novel bacterial ADP-ribosylating toxins: structure and function</article-title>. <source hwp:id="source-3">Nat. Rev. Microbiol.</source> <volume>12</volume>, <fpage>599</fpage>–<lpage>611</lpage> (<year>2014</year>).</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Hauser A.R."><surname>Hauser</surname>, <given-names>A.R.</given-names></string-name> <article-title hwp:id="article-title-5">The type III secretion system of Pseudomonas aeruginosa: infection by injection</article-title>. <source hwp:id="source-4">Nat. Rev. Microbiol.</source> <volume>7</volume>, <fpage>654</fpage>–<lpage>665</lpage> (<year>2009</year>).</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Coburn J."><surname>Coburn</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wyatt R.T."><surname>Wyatt</surname>, <given-names>R.T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Iglewski B.H."><surname>Iglewski</surname>, <given-names>B.H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Gill D.M."><surname>Gill</surname>, <given-names>D.M.</given-names></string-name> <article-title hwp:id="article-title-6">Several GTP-binding proteins, including p21c-H-ras, are preferred substrates of Pseudomonas aeruginosa exoenzyme S</article-title>. <source hwp:id="source-5">J. Biol. Chem.</source> <volume>264</volume>, <fpage>9004</fpage>–<lpage>9008</lpage> (<year>1989</year>).</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Henriksson M.L."><surname>Henriksson</surname>, <given-names>M.L.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-7">Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo</article-title>. <source hwp:id="source-6">Biochem. J.</source> <volume>367</volume>, <fpage>617</fpage>–<lpage>628</lpage> (<year>2002</year>).</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Maresso A.W."><surname>Maresso</surname>, <given-names>A.W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Baldwin M.R."><surname>Baldwin</surname>, <given-names>M.R.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Barbieri J.T."><surname>Barbieri</surname>, <given-names>J.T.</given-names></string-name> <article-title hwp:id="article-title-8">Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS</article-title>. <source hwp:id="source-7">J. Biol. Chem.</source> <volume>279</volume>, <fpage>38402</fpage>–<lpage>38408</lpage> (<year>2004</year>).</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Coburn J."><surname>Coburn</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dillon S.T."><surname>Dillon</surname>, <given-names>S.T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Iglewski B.H."><surname>Iglewski</surname>, <given-names>B.H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Gill D.M."><surname>Gill</surname>, <given-names>D.M.</given-names></string-name> <article-title hwp:id="article-title-9">Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin</article-title>. <source hwp:id="source-8">Infect. Immun.</source> <volume>57</volume>, <fpage>996</fpage>–<lpage>998</lpage> (<year>1989</year>).</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Jansson A.L."><surname>Jansson</surname>, <given-names>A.L.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-10">Exoenzyme S of Pseudomonas aeruginosa is not able to induce apoptosis when cells express activated proteins, such as Ras or protein kinase B/Akt</article-title>. <source hwp:id="source-9">Cell. Microbiol.</source> <volume>8</volume>, <fpage>815</fpage>–<lpage>822</lpage> (<year>2006</year>).</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1"><label>10.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Deng Q."><surname>Deng</surname>, <given-names>Q.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sun J."><surname>Sun</surname>, <given-names>J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Barbieri J.T."><surname>Barbieri</surname>, <given-names>J.T.</given-names></string-name> <article-title hwp:id="article-title-11">Uncoupling Crk signal transduction by Pseudomonas exoenzyme T</article-title>. <source hwp:id="source-10">J. Biol. Chem.</source> <volume>280</volume>, <fpage>35953</fpage>–<lpage>35960</lpage> (<year>2005</year>).</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Cohen M.S."><surname>Cohen</surname>, <given-names>M.S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Chang P."><surname>Chang</surname>, <given-names>P.</given-names></string-name> <article-title hwp:id="article-title-12">Insights into the biogenesis, function, and regulation of ADP-ribosylation</article-title>. <source hwp:id="source-11">Nat. Chem. Biol.</source> <volume>14</volume>, <fpage>236</fpage>–<lpage>243</lpage> (<year>2018</year>).</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><label>12.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Rangel S.M."><surname>Rangel</surname>, <given-names>S.M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Diaz M.H."><surname>Diaz</surname>, <given-names>M.H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Knoten C.A."><surname>Knoten</surname>, <given-names>C.A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang A."><surname>Zhang</surname>, <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Hauser A.R."><surname>Hauser</surname>, <given-names>A.R.</given-names></string-name> <article-title hwp:id="article-title-13">The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia</article-title>. <source hwp:id="source-12">PLoS Pathog</source>. <volume>11</volume>, <fpage>e1004945</fpage> (<year>2015</year>).</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Fu H."><surname>Fu</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Coburn J."><surname>Coburn</surname>, <given-names>J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Collier R.J."><surname>Collier</surname>, <given-names>R.J.</given-names></string-name> <article-title hwp:id="article-title-14">The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family</article-title>. <source hwp:id="source-13">Proc. Natl. Acad. Sci. U.S.A.</source> <volume>90</volume>, <fpage>2320</fpage>–<lpage>2324</lpage> (<year>1993</year>).</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><label>14.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Liu S."><surname>Liu</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yahr T.L."><surname>Yahr</surname>, <given-names>T.L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Frank D.W."><surname>Frank</surname>, <given-names>D.W.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Barbieri J.T."><surname>Barbieri</surname>, <given-names>J.T.</given-names></string-name> <article-title hwp:id="article-title-15">Biochemical relationships between the 53-kilodalton (Exo53) and 49-kilodalton (ExoS) forms of exoenzyme S of Pseudomonas aeruginosa</article-title>. <source hwp:id="source-14">J. Bacteriol.</source> <volume>179</volume>, <fpage>1609</fpage>–<lpage>1613</lpage> (<year>1997</year>).</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1 xref-ref-15-2"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Sluchanko N.N."><surname>Sluchanko</surname>, <given-names>N.N.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Gusev N.B."><surname>Gusev</surname>, <given-names>N.B.</given-names></string-name> <article-title hwp:id="article-title-16">Moonlighting chaperone-like activity of the universal regulatory 14-3-3 proteins</article-title>. <source hwp:id="source-15">FEBS J</source>. <volume>284</volume>, <fpage>1279</fpage>–<lpage>1295</lpage> (<year>2017</year>).</citation></ref><ref id="c16" hwp:id="ref-16"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Gardino A.K."><surname>Gardino</surname>, <given-names>A.K.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Yaffe M.B."><surname>Yaffe</surname>, <given-names>M.B.</given-names></string-name> <article-title hwp:id="article-title-17">14-3-3 proteins as signaling integration points for cell cycle control and apoptosis</article-title>. <source hwp:id="source-16">Sem. Cell Dev. Biol.</source> <volume>22</volume>, <fpage>688</fpage>–<lpage>695</lpage> (<year>2011</year>).</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1 xref-ref-17-2"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Obsil T."><surname>Obsil</surname>, <given-names>T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Obsilova V."><surname>Obsilova</surname>, <given-names>V.</given-names></string-name> <article-title hwp:id="article-title-18">Structural basis of 14-3-3 protein functions</article-title>. <source hwp:id="source-17">Se Sem. Cell Dev. Biol.</source> <volume>22</volume>, <fpage>663</fpage>–<lpage>672</lpage> (<year>2011</year>).</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Sluchanko N.N."><surname>Sluchanko</surname>, <given-names>N.N.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Roman S.G."><surname>Roman</surname>, <given-names>S.G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chebotareva N.A."><surname>Chebotareva</surname>, <given-names>N.A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Gusev N.B."><surname>Gusev</surname>, <given-names>N.B.</given-names></string-name> <article-title hwp:id="article-title-19">Chaperone-like activity of monomeric human 14-3-3zeta on different protein substrates</article-title>. <source hwp:id="source-18">Arch. Biochem. Biophys.</source> <volume>549</volume>, <fpage>32</fpage>–<lpage>39</lpage> (<year>2014</year>).</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Masters S.C."><surname>Masters</surname>, <given-names>S.C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pederson K.J."><surname>Pederson</surname>, <given-names>K.J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang L."><surname>Zhang</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barbieri J.T."><surname>Barbieri</surname>, <given-names>J.T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Fu H."><surname>Fu</surname>, <given-names>H.</given-names></string-name> <article-title hwp:id="article-title-20">Interaction of 14-3-3 with a nonphosphorylated protein ligand, exoenzyme S of Pseudomonas aeruginosa</article-title>. <source hwp:id="source-19">Biochemistry</source> <volume>38</volume>, <fpage>5216</fpage>–<lpage>5221</lpage> (<year>1999</year>).</citation></ref><ref id="c20" hwp:id="ref-20"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Henriksson M.L."><surname>Henriksson</surname>, <given-names>M.L.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-21">A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo</article-title>. <source hwp:id="source-20">Eur. J. Biochem.</source> <volume>269</volume>, <fpage>4921</fpage>–<lpage>4929</lpage> (<year>2002</year>).</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1 xref-ref-21-2 xref-ref-21-3 xref-ref-21-4 xref-ref-21-5"><label>21.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Yang X."><surname>Yang</surname>, <given-names>X.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-22">Structural basis for protein-protein interactions in the 14-3-3 protein family</article-title>. <source hwp:id="source-21">Proc. Natl. Acad. Sci. U.S.A.</source> <volume>103</volume>, <fpage>17237</fpage>–<lpage>17242</lpage> (<year>2006</year>).</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1 xref-ref-22-2"><label>22.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Yasmin L."><surname>Yasmin</surname>, <given-names>L.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-23">Delineation of exoenzyme S residues that mediate the interaction with 14-3-3 and its biological activity</article-title>. <source hwp:id="source-22">FEBS J</source>. <volume>273</volume>, <fpage>638</fpage>–<lpage>646</lpage> (<year>2006</year>).</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1 xref-ref-23-2"><label>23.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Ottmann C."><surname>Ottmann</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-24">Phosphorylation-independent interaction between 14-3-3 and exoenzyme S: from structure to pathogenesis</article-title>. <source hwp:id="source-23">EMBO J</source>. <volume>26</volume>, <fpage>902</fpage>–<lpage>913</lpage> (<year>2007</year>).</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1 xref-ref-24-2"><label>24.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Yasmin L."><surname>Yasmin</surname>, <given-names>L.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-25">Electrostatic interactions play a minor role in the binding of ExoS to 14-3-3 proteins</article-title>. <source hwp:id="source-24">Biochem. J.</source> <volume>427</volume>, <fpage>217</fpage>–<lpage>224</lpage> (<year>2010</year>).</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><label>25.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Braun M."><surname>Braun</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-26">Characterization of an ADP-ribosyltransferase toxin (AexT) from Aeromonas salmonicida subsp. salmonicida</article-title>. <source hwp:id="source-25">J. Bacteriol.</source> <volume>184</volume>, <fpage>1851</fpage>–<lpage>1858</lpage> (<year>2002</year>).</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><label>26.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Kodama T."><surname>Kodama</surname>, <given-names>T.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-27">Identification and characterization of VopT, a novel ADP-ribosyltransferase effector protein secreted via the Vibrio parahaemolyticus type III secretion system 2</article-title>. <source hwp:id="source-26">Cell. Microbiol.</source> <volume>9</volume>, <fpage>2598</fpage>–<lpage>2609</lpage> (<year>2007</year>).</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1"><label>27.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Glas A."><surname>Glas</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-28">Constrained peptides with target-adapted cross-links as inhibitors of a pathogenic protein-protein interaction</article-title>. <source hwp:id="source-27">Angew. Chem. Intl. Ed.</source> <volume>53</volume>, <fpage>2489</fpage>–<lpage>2493</lpage> (<year>2014</year>).</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1"><label>28.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Kruger D.M."><surname>Kruger</surname>, <given-names>D.M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-29">Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein-Protein Interactions</article-title>. <source hwp:id="source-28">J. Med. Chem.</source> <volume>60</volume>, <fpage>8982</fpage>–<lpage>8988</lpage> (<year>2017</year>).</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1 xref-ref-29-2"><label>29.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Ravulapalli R."><surname>Ravulapalli</surname>, <given-names>R.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-30">Characterization of Vis Toxin, a Novel ADP-Ribosyltransferase from Vibrio splendidus</article-title>. <source hwp:id="source-29">Biochemistry</source> <volume>54</volume>, <fpage>5920</fpage>–<lpage>5936</lpage> (<year>2015</year>).</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1 xref-ref-30-2 xref-ref-30-3"><label>30.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Pinto A.F."><surname>Pinto</surname>, <given-names>A.F.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-31">Identification of Inhibitors of Pseudomonas aeruginosa Exotoxin-S ADP-Ribosyltransferase Activity</article-title>. <source hwp:id="source-30">J. Biomol. Screen.</source> <volume>21</volume>, <fpage>590</fpage>–<lpage>595</lpage> (<year>2016</year>).</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><label>31.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Maiti R."><surname>Maiti</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Van Domselaar G.H."><surname>Van Domselaar</surname>, <given-names>G.H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang H."><surname>Zhang</surname>, <given-names>H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Wishart D.S."><surname>Wishart</surname>, <given-names>D.S.</given-names></string-name> <article-title hwp:id="article-title-32">SuperPose: a simple server for sophisticated structural superposition</article-title>. <source hwp:id="source-31">Nucl. Acids Res.</source> <volume>32</volume>, <fpage>W590</fpage>–<lpage>594</lpage> (<year>2004</year>).</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Krissinel E."><surname>Krissinel</surname>, <given-names>E.</given-names></string-name> <article-title hwp:id="article-title-33">Stock-based detection of protein oligomeric states in jsPISA</article-title>. <source hwp:id="source-32">Nucl. Acids Res.</source> <volume>43</volume>, <fpage>W314</fpage>–<lpage>319</lpage> (<year>2015</year>).</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>33.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Sijbesma E."><surname>Sijbesma</surname>, <given-names>E.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-34">Identification of Two Secondary Ligand Binding Sites in 14-3-3 Proteins Using Fragment Screening</article-title>. <source hwp:id="source-33">Biochemistry</source> <volume>56</volume>, <fpage>3972</fpage>–<lpage>3982</lpage> (<year>2017</year>).</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><label>34.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Fieldhouse R.J."><surname>Fieldhouse</surname>, <given-names>R.J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Turgeon Z."><surname>Turgeon</surname>, <given-names>Z.</given-names></string-name>, <string-name name-style="western" hwp:sortable="White D."><surname>White</surname>, <given-names>D.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Merrill A.R."><surname>Merrill</surname>, <given-names>A.R.</given-names></string-name> <article-title hwp:id="article-title-35">Cholera- and anthrax-like toxins are among several new ADP-ribosyltransferases</article-title>. <source hwp:id="source-34">PLoS computational biology</source> <volume>6</volume>, <fpage>e1001029</fpage> (<year>2010</year>).</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><label>35.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Radics J."><surname>Radics</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Konigsmaier L."><surname>Konigsmaier</surname>, <given-names>L.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Marlovits T.C."><surname>Marlovits</surname>, <given-names>T.C.</given-names></string-name> <article-title hwp:id="article-title-36">Structure of a pathogenic type 3 secretion system in action</article-title>. <source hwp:id="source-35">Nat. Struct. Mol. Biol.</source> <volume>21</volume>, <fpage>82</fpage>–<lpage>87</lpage> (<year>2014</year>).</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><label>36.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Alblova M."><surname>Alblova</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-37">Molecular basis of the 14-3-3 protein-dependent activation of yeast neutral trehalase Nth1</article-title>. <source hwp:id="source-36">Proc. Natl. Acad. Sci. U.S.A.</source> <volume>114</volume>, <fpage>E9811</fpage>–<lpage>E9820</lpage> (<year>2017</year>).</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><label>37.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Obsil T."><surname>Obsil</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ghirlando R."><surname>Ghirlando</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Klein D.C."><surname>Klein</surname>, <given-names>D.C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ganguly S."><surname>Ganguly</surname>, <given-names>S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Dyda F."><surname>Dyda</surname>, <given-names>F.</given-names></string-name> <article-title hwp:id="article-title-38">Crystal structure of the 14-3-3zeta:serotonin N-acetyltransferase complex. a role for scaffolding in enzyme regulation</article-title>. <source hwp:id="source-37">Cell</source> <volume>105</volume>, <fpage>257</fpage>–<lpage>267</lpage> (<year>2001</year>).</citation></ref><ref id="c38" hwp:id="ref-38"><label>38.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Sluchanko N.N."><surname>Sluchanko</surname>, <given-names>N.N.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-39">Structural Basis for the Interaction of a Human Small Heat Shock Protein with the 14-3-3 Universal Signaling Regulator</article-title>. <source hwp:id="source-38">Structure</source> <volume>25</volume>, <fpage>305</fpage>–<lpage>316</lpage> (<year>2017</year>).</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><label>39.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Taoka K."><surname>Taoka</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-40">14-3-3 proteins act as intracellular receptors for rice Hd3a florigen</article-title>. <source hwp:id="source-39">Nature</source> <volume>476</volume>, <fpage>332</fpage>–<lpage>335</lpage> (<year>2011</year>).</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><label>40.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Sun J."><surname>Sun</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Maresso A.W."><surname>Maresso</surname>, <given-names>A.W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kim J.J."><surname>Kim</surname>, <given-names>J.J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Barbieri J.T."><surname>Barbieri</surname>, <given-names>J.T.</given-names></string-name> <article-title hwp:id="article-title-41">How bacterial ADP-ribosylating toxins recognize substrates</article-title>. <source hwp:id="source-40">Nat. Struct. Mol. Biol.</source> <volume>11</volume>, <fpage>868</fpage>–<lpage>876</lpage> (<year>2004</year>).</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1"><label>41.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Stevers L.M."><surname>Stevers</surname>, <given-names>L.M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-42">Modulators of 14-3-3 Protein-Protein Interactions</article-title>. <source hwp:id="source-41">J. Med. Chem.</source> <volume>61</volume>, <fpage>3755</fpage>–<lpage>3778</lpage> (<year>2017</year>).</citation></ref><ref id="c42" hwp:id="ref-42"><label>42.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Engh R.A."><surname>Engh</surname>, <given-names>R.A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Huber R."><surname>Huber</surname>, <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-43">Accurate Bond and Angle Parameters for X-Ray Protein-Structure Refinement</article-title>. <source hwp:id="source-42">Acta Crystallogr. A.</source> <volume>47</volume>, <fpage>392</fpage>–<lpage>400</lpage> (<year>1991</year>).</citation></ref><ref id="c43" hwp:id="ref-43"><label>43.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Chen V.B."><surname>Chen</surname>, <given-names>V.B.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-44">MolProbity: all-atom structure validation for macromolecular crystallography</article-title>. <source hwp:id="source-43">Acta Crystallogr. D. Biol. Crystallogr.</source> <volume>66</volume>, <fpage>12</fpage>–<lpage>21</lpage> (<year>2010</year>).</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1"><label>44.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Szczepankiewicz B.G."><surname>Szczepankiewicz</surname>, <given-names>B.G.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-45">Synthesis of carba-NAD and the structures of its ternary complexes with SIRT3 and</article-title> <source hwp:id="source-44">SIRT5. J. Org. Chem</source>. <volume>77</volume>, <fpage>7319</fpage>–<lpage>7329</lpage> (<year>2012</year>).</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><label>45.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Bogomolovas J."><surname>Bogomolovas</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Simon B."><surname>Simon</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sattler M."><surname>Sattler</surname>, <given-names>M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Stier G."><surname>Stier</surname>, <given-names>G.</given-names></string-name> <article-title hwp:id="article-title-46">Screening of fusion partners for high yield expression and purification of bioactive viscotoxins</article-title>. <source hwp:id="source-45">Protein Expr. Purif.</source> <volume>64</volume>, <fpage>16</fpage>–<lpage>23</lpage> (<year>2009</year>).</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><label>46.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Keates T."><surname>Keates</surname>, <given-names>T.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-47">Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation</article-title>. <source hwp:id="source-46">New Biotechnol</source>. <volume>29</volume>, <fpage>515</fpage>–<lpage>525</lpage> (<year>2012</year>).</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1 xref-ref-47-2"><label>47.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Sparta K.M."><surname>Sparta</surname>, <given-names>K.M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Krug M."><surname>Krug</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Heinemann U."><surname>Heinemann</surname>, <given-names>U.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mueller U."><surname>Mueller</surname>, <given-names>U.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Weiss M.S."><surname>Weiss</surname>, <given-names>M.S.</given-names></string-name> <article-title hwp:id="article-title-48">XDSAPP2.0</article-title>. <source hwp:id="source-47">J. Appl. Crystallogr</source>. <volume>49</volume>, <fpage>1085</fpage>–<lpage>1092</lpage> (<year>2016</year>).</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1"><label>48.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Kabsch W. Xds"><surname>Kabsch</surname>, <given-names>W. Xds</given-names></string-name>. <source hwp:id="source-48">Acta Crystallogr. D. Biol. Crystallogr.</source> <volume>66</volume>, <fpage>125</fpage>–<lpage>132</lpage> (<year>2010</year>).</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1"><label>49.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Evans P."><surname>Evans</surname>, <given-names>P.</given-names></string-name> <article-title hwp:id="article-title-49">Scaling and assessment of data quality</article-title>. <source hwp:id="source-49">Acta Crystallogr. D. Biol. Crystallogr.</source> <volume>62</volume>, <fpage>72</fpage>–<lpage>82</lpage> (<year>2006</year>).</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1"><label>50.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="McCoy A.J."><surname>McCoy</surname>, <given-names>A.J.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-50">Phaser crystallographic software</article-title>. <source hwp:id="source-50">J Appl Crystallogr</source> <volume>40</volume>, <fpage>658</fpage>–<lpage>674</lpage> (<year>2007</year>).</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1"><label>51.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Afonine P.V."><surname>Afonine</surname>, <given-names>P.V.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-51">Towards automated crystallographic structure refinement with phenix.refine</article-title>. <source hwp:id="source-51">Acta Crystallogr. D. Biol. Crystallogr.</source> <volume>68</volume>, <fpage>352</fpage>–<lpage>367</lpage> (<year>2012</year>).</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1"><label>52.</label><citation publication-type="book" citation-type="book" ref:id="342659v1.52" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Bricogne G."><surname>Bricogne</surname>, <given-names>G.</given-names></string-name> <etal>et al.</etal> <source hwp:id="source-52">BUSTER. Edn. version 2.10.2</source>. (<publisher-name>Global Phasing Ltd.</publisher-name>, <publisher-loc>Cambridge, United Kingdom</publisher-loc>; <year>2016</year>).</citation></ref><ref id="c53" hwp:id="ref-53" hwp:rev-id="xref-ref-53-1"><label>53.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Emsley P."><surname>Emsley</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lohkamp B."><surname>Lohkamp</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Scott W.G."><surname>Scott</surname>, <given-names>W.G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Cowtan K."><surname>Cowtan</surname>, <given-names>K.</given-names></string-name> <article-title hwp:id="article-title-52">Features and development of Coot</article-title>. <source hwp:id="source-53">Acta Crystallogr. D. Biol. Crystallogr.</source> <volume>66</volume>, <fpage>486</fpage>–<lpage>501</lpage> (<year>2010</year>).</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1"><label>54.</label><citation publication-type="journal" citation-type="journal" ref:id="342659v1.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Gietz R.D."><surname>Gietz</surname>, <given-names>R.D.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Woods R.A."><surname>Woods</surname>, <given-names>R.A.</given-names></string-name> <article-title hwp:id="article-title-53">Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method</article-title>. <source hwp:id="source-54">Meth. Enzymol.</source> <volume>350</volume>, <fpage>87</fpage>–<lpage>96</lpage> (<year>2002</year>).</citation></ref></ref-list></back></article>
